BridgeMD
New treatment option for HIV-1-infection
Official title Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
ClinicalTrials.gov ID: NCT06648629
What this study is testing
- What it's testing
- Alcohol consumption is a critical factor in HIV treatment that significantly contributes to poor treatment-related outcomes. Randomized clinical trials (RCTs) of alcohol interventions for people with HIV (PWH) have had limited success, perhaps due to an increasingly recognized co-morbitity of co-occurring hazardous alcohol use and other mental health-related problems among PWH.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Living with HIV
- Drink at unhealthy levels based on self-reported answers to the AUDIT-C, referencing drinking over the previous 3 months [score of ≥4 (men) or ≥3...
- on HIV treatment and are
- 18 years or older.
- Read at an 8th grade level
You likely can't join if
- Anyone with a score = 12 on the AUDIT-C will be excluded.
- Anyone with a score ≥20 on the PHQ-9, indicative of severe depression, will be excluded.
- Anyone with a score of ≥15 on the GAD-7, indicative of severe anxiety, will be excluded. Referrals for mental health treatment will be given to all...
See the full eligibility criteria
- Living with HIV
- Drink at unhealthy levels based on self-reported answers to the AUDIT-C, referencing drinking over the previous 3 months [score of ≥4 (men) or ≥3 (women) will be used to identify eligible participants]
- on HIV treatment and are
- 18 years or older.
- Read at an 8th grade level
- Can provide a physical address
- Able to provide informed consent
- Anyone with a score = 12 on the AUDIT-C will be excluded.
- Anyone with a score ≥20 on the PHQ-9, indicative of severe depression, will be excluded.
- Anyone with a score of ≥15 on the GAD-7, indicative of severe anxiety, will be excluded. Referrals for mental health treatment will be given to all participants who screen out.
The study team makes the final eligibility decision.
Where it's taking place
- Syracuse, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Syracuse, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.